| |
 David A. Costa, Ph.D.
Registered Patent Attorney
Email:
dcosta@addmg.com
Telephone:
305-374-8303
Facsimile:
305-374-8306
Miami
Practice Areas:
Admitted:
- 2010: United States Patent and Trademark Office
Education:
- 2011: J.D., with honors, University of Florida Levin College of Law, Certificate Degree in Intellectual Property
- 2006: M.S. in Biomedical Engineering (with focus on robotics)
- 2005: Ph.D. in Medical Science, University of South Florida College of Medicine, Department of Biochemistry and Molecular Biology, University Graduate Fellowship, College of Medicine Honor Counsel
- 1999: B.S. in Microbiology (with minors in Chemistry & Sociology), with honors, University of Florida
Biography:
Dr. Costa is a Registered Patent Attorney specializing in the preparation, filing, and prosecution of complex international and domestic pharmaceutical, chemical, bio-chemical, and biological patents. In addition, Dr. Costa also assists clients in patent prosecution relating to business methods, computer systems and software, based upon his programming experience in various languages including C, C++, Visual Basic and assembly language. He also has experience in industrial design and processes including machining knowledge utilizing milling machines, metal lathes, and surface grinding, as well as proficiency in gas metal arc welding, shielded metal arc welding and oxy-fuel methods.
Dr. Costa is active in the Miami community, including involvement in HYPE Miami and the Technology Committee of the Greater Miami Chamber of Commerce. He is an honors graduate of the University of Florida Levin College of Law, where he received a Juris Doctorate and Certificate Degree in Intellectual Property Law. While at Florida Law, he received the book awards (highest grade) in Patent Law and International Intellectual Property Law. In addition, he served on the Editorial Board of the Journal of Technology Law & Policy.
Prior to attending law school, Dr. Costa received his Ph.D. in the Medical Sciences (emphasis in Biochemistry and Molecular Biology) and his M.S. in Biomedical Engineering all from the University of South Florida (USF). His master's studies focused primarily on the role of robotics in medical engineering and design. His Ph.D. dissertation focused on prevention of Alzheimer's Disease. While a graduate student at USF, he served on the College of Medicine Honors Counsel. He received his B.S. with honors in Microbiology (minor in Chemistry) from the University of Florida.
Dr. Costa's technical experience includes an assistant professorship at the USF Department of Engineering, and a fellowship at the Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute.
Recognition:
- ABA-BNA Award of Excellence in Intellectual Property Law 2011
- Book Award in Patent Law 2009
- Book Award in International Intellectual Property Law 2010
- Superior Presentation, USF Health Science Center Annual Research Day 2001
Affiliations:
- BioFlorida
- Intellectual Property Law Association of Florida
- Greater Miami Chamber of Commerce (Technology & Bioscience Committee)
- Association of University Technology Managers
Publications:
- In Pari Delicto and Crop Gene Patents: An Equitable Defense for Innocently Infringing Farmers, 3 Ky. J. Equine. Agric. & Nat. Resource (forthcoming).
- Venor v. AutoDesk: An Erosion of the First Sale Doctrine, 30 Rutgers L. Rec. 2011
- L.N.G. Nilsson, S. Gografe, D.A. Costa, T. Hughes, D. Dressler, H. Potter. Dual role of Apolipoprotein E in Alzheimer?s disease: Blood apoE reduces hyperocholestrolemia and brain amyloid; brain apoE promotes amyloid. Submitted for Publication, 2011.
- D. A. Costa, J. Cracchiolo, A. D. Bachstetter, T. Hughes, K.R. Bales, S.M. Paul, R. F. Mervis, G. W. Arendash, H. Potter. Enrichment improves cognition in AD mice by amyloid related and unrelated mechanisms. Neurobiol Aging 2006 May 24.
- D. A. Costa, L.N.G. Nilsson, K.R. Bales, S.M. Paul, H. Potter. (2004). Apolipoprotein is required for the formation of filamentous amyloid, but not for amorphous Aß deposition, in an AßPP/PS double transgenic mouse model of Alzheimer's disease. J Alzheimer's Disease 6(5): 509?519.
- G.W. Arendash, M. Garcia, D. A. Costa, J. Cracchiolo, I. Wefes, H. Potter (2004). Environmental enrichment improves cognition in aged Alzheimer's transgenic mice despite stable beta amyloid deposition. Neuroreport 15(11): 1751?4.
- Leighty R, L.N.G. Nilsson, H. Potter, D. A. Costa, M. Low, K.R. Bales, S.M. Paul, G.W. Arendash. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in A beta deposition. Behav Brain Res 153(1): 107?21.
- L.N.G. Nilsson, G.W. Arendash, R. Leighty, D. A. Costa, M. Low, M. Garcia, J. Cracchiolo, A. Rojiani, X. Wu, K.R. Bales, S.M. Paul, H. Potter. Cognitive impairment in PDAPP mice depends on ApoE and ACT catalyzed amyloid formation. Neurobiol Aging 25(9): 1153 67.
|
|
